Coronavirus Infection clinical trials at UC Health
1 research study open to eligible people
open to eligible people ages 18 years and up
The main purpose of this study is to evaluate the activity of low dose oral selinexor (KPT-330) and to evaluate the clinical recovery, the viral load, length of hospitalization and the rate of morbidity and mortality in participants with severe COVID-19 compared to placebo.
at UC Davis UCLA